✦ LIBER ✦

Comparative Effectiveness of Long-Acting Risperidone in New Zealand

✍ Scribed by Christopher Carswell, Dr Amanda Wheeler, Jane Vanderpyl, Elizabeth Robinson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PMH10 ECONOMIC ANALYSIS OF RISPERIDONE L

✍ A Davies; R Schrover; S Crowley; AM Neville 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PMH51 COST-EFFECTIVENESS EVALUATION OF L

✍ J Locklear; N Edwards; MF Rupnow; R Diamond 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB

PMH23 COST-EFFECTIVENESS EVALUATION OF L

✍ N Edwards; M Rupnow; CL Pashos; MF Botteman; J Locklear; R Diamond 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

Comparative efficacy and safety of long-

✍ Pierre Chue; Marielle Eerdekens; Ilse Augustyns; Bernard Lachaux; Peter Molčan; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 142 KB

PMH21 THE COST-EFFECTIVENESS OF RISPERID

✍ J Damen; BMS Heeg; M Lothgren; BA Van Hout 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

PMH31 Cost-Effectiveness of Long-Acting

✍ T. Dilla; P. O'Donohoe; J. Möller; M. Álvarez; J. Sacristán; L. San; M. Happich; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB